MedTrace Logo

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

NCT04484688 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-07-23

No results posted yet for this study

Summary

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

Conditions

  • Patient Participation

Interventions

DRUG

perindopril-bisoprolol

outpatients with permanent atrial fibrillation and with preserved ejection fraction

Sponsors & Collaborators

  • Aversi Clinic

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-09-01
Completion
2021-12-01

Countries

  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04484688 on ClinicalTrials.gov